MRS. ROBIN RENEE LEE, RPH
Pharmacy at Bob Wilson Dr, San Diego, CA
License number
California 26018270A
Category
Pharmacy
Type
Pharmacist
Address
Address
34800 Bob Wilson Dr, San Diego, CA 92134
Phone
(619) 532-8431
(619) 299-9360
(619) 299-9360
Personal information
See more information about ROBIN RENEE LEE at radaris.comName
Address
Phone
4945 Anza St, San Francisco, CA 94121
508 7Th St, Manhattan Beach, CA 90266
447-325 Jakes Ln, Doyle, CA 96109
4739 Hayter Ave, Lakewood, CA 90712
55 Ambrosia Way, Bay Point, CA 94565
Professional information
See more information about ROBIN RENEE LEE at trustoria.com
Robin Lee - San Diego, CA
Robin Lee - San Diego, CA
Work:
Nitto Denko Technical
Senior Scientist Nitto Denko Technical - Oceanside, CA
Formulation Associate Paxvax, Inc - San Diego, CA
QC Associate III Amylin Pharmaceuticals, Inc - San Diego, CA
Research Associate II Cardinal Health, Inc - San Diego, CA
Senior Research Associate On Site - Thousand Oaks, CA
Research Associate Lab Support - Northridge, CA
QC Chemist
Senior Scientist Nitto Denko Technical - Oceanside, CA
Formulation Associate Paxvax, Inc - San Diego, CA
QC Associate III Amylin Pharmaceuticals, Inc - San Diego, CA
Research Associate II Cardinal Health, Inc - San Diego, CA
Senior Research Associate On Site - Thousand Oaks, CA
Research Associate Lab Support - Northridge, CA
QC Chemist
Education:
University of California - Davis, CA
Bachelor of Science in Microbiology
Bachelor of Science in Microbiology
Method Of Producing Lipid Nanoparticles For Drug Delivery
Method Of Producing Lipid Nanoparticles For Drug Delivery
US Patent:
2013011, May 9, 2013
Filed:
Nov 5, 2012
Appl. No.:
13/669078
Inventors:
Nitto Denko Corporation - Osaka, JP
Richard P. Witte - San Diego CA, US
Priya Karmali - San Diego CA, US
Robin Lee - San Diego CA, US
David Webb - Oceanside CA, US
Violetta Akopian - Oceanside CA, US
Richard P. Witte - San Diego CA, US
Priya Karmali - San Diego CA, US
Robin Lee - San Diego CA, US
David Webb - Oceanside CA, US
Violetta Akopian - Oceanside CA, US
Assignee:
NITTO DENKO CORPORATION - Osaka
International Classification:
A61K 9/127, A61K 31/7105, B82Y 5/00, B82Y 40/00
US Classification:
424450, 514 44 R, 977800, 977907
Abstract:
What is described is a method for preparing a liposome that efficiently encapsulates a negatively charged therapeutic polymer, e.g., siRNA. The process involves preparing a lipid mixture comprising a cationic lipid in a water miscible organic solvent, such as ethanol, at a concentration of 2.3 mg/ml, and adding this solution to the polymer dissolved in water to a final concentration of 35% ethanol in water. The final charge ratio of drug:lipid is 1:2.5. The resulting nanoparticles have a mean size of 50 to 150 nm.
Single Use System For Sterilely Producing Lipid-Nucleic Acid Particles
Single Use System For Sterilely Producing Lipid-Nucleic Acid Particles
US Patent:
2013016, Jun 27, 2013
Filed:
Nov 5, 2012
Appl. No.:
13/669217
Inventors:
Nitto Denko Corporation - Osaka, JP
Richard P. Witte - San Diego CA, US
Priya Karmali - San Diego CA, US
Robin Lee - San Diego CA, US
David Webb - Oceanside CA, US
Richard P. Witte - San Diego CA, US
Priya Karmali - San Diego CA, US
Robin Lee - San Diego CA, US
David Webb - Oceanside CA, US
Assignee:
NITTO DENKO CORPORATION - Osaka
International Classification:
A61K 9/48
US Classification:
425 5
Abstract:
What is described is a process of forming lipid-nucleic acid nanoparticles simply and reproducibly under aseptic conditions comprising single use components.
Sustained Release Formulations Using Non-Aqueous Carriers
Sustained Release Formulations Using Non-Aqueous Carriers
US Patent:
2011021, Sep 1, 2011
Filed:
Sep 4, 2009
Appl. No.:
13/060225
Inventors:
Mary L. Houchin - Rockville MD, US
Robin H. Lee - San Diego CA, US
Hong Qi - San Diego CA, US
Greg Oehrtman - San Diego CA, US
Robert N. Jennings - San Diego CA, US
Scott H. Coleman - San Diego CA, US
Robin H. Lee - San Diego CA, US
Hong Qi - San Diego CA, US
Greg Oehrtman - San Diego CA, US
Robert N. Jennings - San Diego CA, US
Scott H. Coleman - San Diego CA, US
International Classification:
A61K 9/00, A61K 38/00, A61K 38/22, A61K 38/28, A61K 38/38, A61K 31/60, A61K 31/135, A61P 3/10, A61P 3/08, A61P 3/00, A61P 3/04, A61P 3/06
US Classification:
424400, 514 48, 514 58, 514 59, 514 69, 514 74, 514159, 514649
Abstract:
The disclosure provides one-component, injectable, sustained release formulations which comprise microspheres containing active pharmaceutical ingredients (e.g., exenatide), wherein the microspheres are suspended in a non-aqueous carrier. The non-aqueous carrier can be an oil, a fractionated oil, triglycerides, diglycerides, monoglycerides, propylene glycol fatty acid diesters, and the like. The formulations offer distinct advantages of long shelf life for the stability and potency of the formulation and sustained release of active pharmaceutical ingredients to reduce the frequency of medication dosing and to increase patient compliance.